Autor
Afiliación
Resumen en ingles
HIV and Mycobacterium tuberculosis (MTB) are two widespread and highly successful microbes whose synergy in pathogenesis has created a significant threat for human health globally. In acknowledgement of this fact, the European Union (EU) has funded a multinational support action, the European Network for global cooperation in the field of AIDS and TB (EUCO-Net), that brings together experts from Europe and those regions that bear the highest burden of HIV/MTB co-infection. Here, we summarise the main outcome of the EUCO-Net project derived from an expert group meeting that took place in Stellenbosch (South Africa) (AIDS/TB Workshop on Research Challenges and Opportunities for Future Collaboration) and the subsequent discussions, and propose priority areas for research and concerted actions that will have impact on future EU calls.
Editor
European Respiratory Society
Referencia
European Network for global cooperation in the field of AIDS and TB (EUCO-Net). Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J, v.36, p.1242–1247, 2010.
DOI
10.1183/09031936.00040910
ISSN
0903-1936
Notas
EUCO-Net collaborators and invited participants in the workshop
were (in alphabetical order): M.A. Alvarez (CONICET, Buenos Aires,
Argentina), P. Arbelaez (Universidad de Antioquia, Medellı´n,
Colombia), F.I. Bastos (FIOCRUZ, Rio de Janeiro, Brazil), B. Berkhout
(University of Amsterdam, Amsterdam, The Netherlands), B.
Bhattacharya (Institute of Post-graduate Medical Education, Kolkata,
India), G. Bocharov (Institute of Numerical Mathematics, Russian
Academy of Sciences, Moscow, Russia), V. Chereshnev (Institute
of Immunology and Physiology, Russian Academy of Sciences,
Yekaterinburg, Russia), P. Cuchı´ (UNAIDS, Geneva, Switzerland),
Martin Da¨umer (Institute of Immunology and Genetics, Kaiserslautern,
Germany), O. Demikhova (Central Research Institute of Tuberculosis,
Russian Academy of Medical Sciences, Moscow, Russia), K. Feldman
(Kuratorium Tuberkulose in der Welt e.V., Gauting, Germany), L.F.
Garcı´a (Universidad de Antioquia), C. Giehl (European Research and
Project Office, Saarbru¨ cken, Germany), A. Gulalia (BPS Women
University, Haryana, India), B. Kampmann (Imperial College London,
London, UK), E. Karamov (D.I. Ivanovsky Institute of Virology, Russian
Academy of Medical Sciences, Moscow, Russia), P. Kebaabetswe
(BOTUSA, Gaborone, Botswana), M. Kiselev (Ministry of Health and
Social Development of the Russian Federation, Moscow, Russia), A-L.
Knellwolf (Istituto Superiore di Sanita`, Rome, Italy), A.L. Kritski(Federal
University of Rio de Janeiro, Rio de Janeiro, Brazil), C. Lange (Research
Center Borstel, Borstel, Germany), C. Lo´pez-Galı´ndez (Instituto de Salud
Carlos III, Madrid, Spain), A. Makone (Community Working Group on
Health, Harare, Zimbabwe), A. Martin (Institute of Tropical Medicine,
Antwerp, Belgium), H. Mayanja-Kizza (College of Health Sciences,
Makerere University, Kampala, Uganda), R. McNerney, (London School
of Hygiene and Tropical Medicine, London, UK), A. Meyerhans
(Saarland University, Saarbru¨ cken, Germany and ICREA, University
Pompeu Fabra, Barcelona, Spain), G.B. Migliori (Fondazione Salvatore
Maugeri, Tradate, Italy), M.G. Morgado (FIOCRUZ), J. Nachega
(Stellenbosch University, Stellenbosch, South Africa), B. Ngwira
(Karonga Prevention Study, Karonga, Malawi), M. Odermarsky
(EATG, Brussels, Belgium), M. Ota (Medical Research Council, Banjul,
The Gambia), J.C. Palomino (Institute of Tropical Medicine, Antwerp,
Belgium), G.E. Pfyffer (Luzerne General Hospital, Luzerne, Switzerland),
W. Preiser (Stellenbosch University), Viviana Ritacco (CONICET),
J. Robledo (Corporacio´n para Investigaciones Biolo´gicas, CIB-UPB,
Medellı´n, Colombia), C. Rodrigues (Hinduja National Hospital,
Mumbai, India), H. Salomo´n (Argentinean National Reference Center
for AIDS, Buenos Aires, Argentina), S. Samper (Institiuto Aragone´s de
Ciencias de la Salud, Zaragoza, Spain), J. Sanchez (Asociacion Civil
Impacta, Salud y Educacion, Lima, Peru), M. Sester (Saarland
University), P. Seth (Seth Research Foundation, Haryana, India), B.
Seti (AIDS and RIGHTS Alliance for Southern Africa, Cape Town, South
Africa), I. Sidorovich (SRC Institute of Immunology, Moscow, Russia),
R. Singla (LRS Institute of Tuberculosis and Respiratory Diseases,New Delhi, India), L. Sonnier (EATG), C. Torti (University of Brescia,
Brescia, Italy), E. Tortoli (Careggi University Hospital, Florence, Italy),
W. Vandevelde (EATG), S. Vella (Istituto Superiore di Sanita`, Rome,
Italy), V. Veloso (FIOCRUZ), H. von Briesen (Fraunhofer IBMT, St
Ingbert, Germany), K. Walia (Indian Council of Medical Research, New
Delhi, India), G. Walzl (Stellenbosch University) and C. Wingfield
(Treatment Action Group, New York, NY, USA).
Compartir